Noémi Brügger, Marcella Pucci, Andrea Bartoli, Manel Mejbri, Anne-Laure Rougemont, Basile Landis, Nils Guinand
{"title":"[Gorham-Stout disease : a rare entity].","authors":"Noémi Brügger, Marcella Pucci, Andrea Bartoli, Manel Mejbri, Anne-Laure Rougemont, Basile Landis, Nils Guinand","doi":"10.53738/REVMED.2025.21.933.47732","DOIUrl":null,"url":null,"abstract":"<p><p>Gorham-Stout disease (GSD) is a rare disorder of unknown etiology, characterized by progressive osteolysis due to abnormal proliferation of lymphatic and vascular tissue within the bone. It can affect the entire skeleton. Symptoms may include bone pain, swelling, and fractures. Diagnosis relies mainly on imaging and histology. Treatment may include bisphosphonates (osteoclast inhibitors), sirolimus (mTOR (mechanistic Target Of Rapamycin) inhibitor), radiotherapy, and surgery. The prognosis is uncertain and depending on the location and severity of the lesions, the condition may be life-threatening. This article reviews the current knowledge about this disease and illustrates it with a clinical case.</p>","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 933","pages":"1744-1748"},"PeriodicalIF":0.0000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue medicale suisse","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53738/REVMED.2025.21.933.47732","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Gorham-Stout disease (GSD) is a rare disorder of unknown etiology, characterized by progressive osteolysis due to abnormal proliferation of lymphatic and vascular tissue within the bone. It can affect the entire skeleton. Symptoms may include bone pain, swelling, and fractures. Diagnosis relies mainly on imaging and histology. Treatment may include bisphosphonates (osteoclast inhibitors), sirolimus (mTOR (mechanistic Target Of Rapamycin) inhibitor), radiotherapy, and surgery. The prognosis is uncertain and depending on the location and severity of the lesions, the condition may be life-threatening. This article reviews the current knowledge about this disease and illustrates it with a clinical case.
期刊介绍:
Destinée aux professionnels de santé, la plateforme revmed.ch regroupe la version électronique de la Revue Médicale Suisse et les applications de formation et d"aide à la prise de décision eRMS. La eRMS est le fruit d’une large collaboration entre institutions et praticiens de Suisse romande.